| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| review article | Q7318358 |
| P2093 | author name string | Martin Prins | |
| Giancarlo Agnelli | |||
| Harry R Büller | |||
| Niklaus Strebel | |||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heparin | Q190016 |
| venous thromboembolism | Q9397786 | ||
| P304 | page(s) | 1451-1456 | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? | |
| P478 | volume | 162 |
| Q91663281 | An anticoagulant that does not cause bleeding - an abrupt stop on the road to the Holy Grail |
| Q42767676 | Biomarkers of Coagulation and Fibrinolysis during Cemented Total Hip Arthroplasty with Pre- versus Postoperative Start of Thromboprophylaxis |
| Q37314088 | Blood loss in cemented THA is not reduced with postoperative versus preoperative start of thromboprophylaxis |
| Q41091253 | Can patients with femoral neck fracture benefit from preoperative thromboprophylaxis?: A prospective randomized controlled trial |
| Q37821476 | Clinical experience with bemiparin |
| Q37019860 | Clinical use of parnaparin in major and minor orthopedic surgery: a review |
| Q36106181 | Compliance with Surgical Care Improvement Project measures and hospital-associated infections following hip arthroplasty |
| Q50560052 | Current Perioperative Anticoagulation Practices in Children with Prosthetic Mechanical Heart Valves. |
| Q81584045 | Deep vein thrombosis |
| Q35953038 | Delayed airway obstruction after internal jugular venous catheterization in a patient with anticoagulant therapy |
| Q35624415 | Dutch guideline on total hip prosthesis |
| Q33660206 | Dutch orthopedic thromboprophylaxis: a 5-year follow-up survey |
| Q50235860 | Early chemoprophylaxis is associated with decreased venous thromboembolism risk without concomitant increase in intraspinal hematoma expansion after traumatic spinal cord injury. |
| Q37466417 | Edoxaban versus enoxaparin for the prevention of venous thromboembolism after total knee or hip arthroplasty: pooled analysis of coagulation biomarkers and primary efficacy and safety endpoints from two phase 3 trials |
| Q35153993 | Effect of heparin on prevention of flap loss in microsurgical free flap transfer: a meta-analysis |
| Q35945900 | Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-V |
| Q46252055 | Emergency reversal of antithrombotic treatment |
| Q34176864 | Evaluating the safety and efficacy of BMI-based preoperative administration of low-molecular-weight heparin in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery |
| Q37230399 | Hemostatic matrix effects on blood loss after total knee arthroplasty: A randomized controlled trial |
| Q35923034 | Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case-control study. |
| Q34641113 | Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgery |
| Q33386637 | Lessons from ximelagatran: issues for future studies evaluating new oral direct thrombin inhibitors for venous thromboembolism prophylaxis in orthopedic surgery |
| Q48279016 | New anticoagulants: perioperative considerations |
| Q36564967 | Oral anticoagulants in development: focus on thromboprophylaxis in patients undergoing orthopaedic surgery |
| Q33386113 | Orthopedic patients with or without thrombophilia. Diagnostic, therapy and peri-operative strategies |
| Q37956135 | Perioperative care for patients with rheumatic diseases |
| Q35752584 | Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines |
| Q28083067 | Pharmacological prevention of venous thromboembolism in orthopaedic surgery |
| Q47353339 | Preoperative low molecular weight heparin as venous thromboembolism prophylaxis in patients at risk for prosthetic infection after knee arthroplasty |
| Q37956637 | Preoperative versus postoperative initiation of thromboprophylaxis following major orthopedic surgery: safety and efficacy of postoperative administration supported by recent trials of new oral anticoagulants |
| Q24632872 | Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines |
| Q33418678 | Prevention of venous thromboembolism in the Enhanced Recovery After Surgery (ERAS) setting: an evidence-based review |
| Q42943031 | Prophylaxis of venous thromboembolism and anticoagulation bridging. Strategies in otorhinolaryngology |
| Q37739087 | Review article: thromboprophylaxis after total hip replacement |
| Q34607209 | Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial |
| Q35219377 | Short- and long-acting synthetic pentasaccharides |
| Q38712791 | Similar Clinical Outcomes with Preoperative and Postoperative Start of Thromboprophylaxis in THA: A Register-based Study |
| Q46137232 | Summary and perspectives. Rivaroxaban |
| Q50136178 | Surgical Technical Evidence Review for Elective Total Joint Replacement Conducted for the AHRQ Safety Program for Improving Surgical Care and Recovery. |
| Q37657993 | The ''critical thrombosis period'' in major orthopedic surgery: when to start and when to stop prophylaxis |
| Q53239383 | The influence of NSAIDs on coumarin sensitivity in patients with CYP2C9 polymorphism after total hip replacement surgery. |
| Q34047801 | Thromboembolic disease in patients with rheumatoid arthritis undergoing joint arthroplasty: Update on prophylaxes. |
| Q36898082 | Thromboprophylaxis for deep vein thrombosis and pulmonary embolism after total joint arthroplasty in a low incidence population |
| Q40247438 | Thromboprophylaxis in total hip-replacement surgery in Europe: acenocoumarol, fondaparinux, dabigatran and rivaroxban |
| Q36461607 | Venous Thromboembolism Following Hip and Knee Replacement Arthroplasty in Korea: A Nationwide Study Based on Claims Registry |
| Q37807917 | Venous thromboembolic prophylaxis for hip fractures |
| Q48559598 | Venous thromboembolism after hepatic resection: analysis of 5,706 patients |
| Q39570122 | Venous thromboembolism after lower limb arthroplasty: is chemical prophylaxis still needed? |
| Q46470737 | Ximelagatran and melagatran vs. low-molecular-weight heparin in major orthopedic surgery: relationship between efficacy and safety and timing of initial administration |
| Q84867382 | [Perioperative thromboprophylaxis in adults] |
| Q87557439 | [Thromboprophylaxis and platelet aggregation inhibitors in spinal surgery: perioperative management] |
Search more.